L
Liping Fu
Researcher at Netherlands Cancer Institute
Publications - 2
Citations - 8
Liping Fu is an academic researcher from Netherlands Cancer Institute. The author has contributed to research in topics: Ductal carcinoma & Population. The author has an hindex of 1, co-authored 2 publications receiving 1 citations.
Papers
More filters
Journal ArticleDOI
Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast.
Maartje van Seijen,Esther H. Lips,Liping Fu,Daniele Giardiello,Frederieke van Duijnhoven,Linda de Munck,Lotte E. Elshof,Alastair M. Thompson,Elinor J. Sawyer,Marc D. Ryser,E. Shelley Hwang,Marjanka K. Schmidt,Marjanka K. Schmidt,Paula H.M. Elkhuizen,Jelle Wesseling,Jelle Wesseling,Michael Schaapveld +16 more
TL;DR: In this paper, the impact of Radiotherapy (RT) following breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS) reduces ipsilateral breast event rates in clinical trials was assessed.
Posted ContentDOI
Genomic profiling defines variable clonal relatedness between invasive breast cancer and primary ductal carcinoma in situ
Esther H. Lips,Tapsi Kumar,Anargyros Megalios,Lindy L. Visser,Michael Sheinman,Angelo Fortunato,Vandna Shah,Marlous Hoogstraat,Emi Sei,Diego Mallo,Maria Roman-Escorza,Ahmed A. Ahmed,Mingchu Xu,Wim Brugman,Karen Clements,Helen Davies,Liping Fu,Anita Grigoriadis,Timothy Hardman,Lorraine M. King,Marielle Krete,Petra Kristel,Michiel de Maaker,Carlo C. Maley,Jeffrey R. Marks,Brian A. Menegaz,Lennart Mulder,Frank Nieboer,Salpie Nowinski,Sarah E Pinder,Jelmar Quist,Carolina Salinas-Souza,Michael Schaapveld,Marjanka K. Schmidt,Abeer M Shaaban,Rana Shami,Mathini Sridharan,John Zhang,Hilary Stobart,Deborah Collyar,Serena Nik-Zainal,Lodewyk F. A. Wessels,Lodewyk F. A. Wessels,E. Shelley Hwang,Nicholas N. Navin,Andrew Futreal,Alastair M. Thompson,Jelle Wesseling,Jelle Wesseling,Elinor J. Sawyer +49 more
TL;DR: In this paper, the authors assessed the clonal relatedness of 143 cases of pure DCIS and their subsequent events using a combination of whole exome, targeted and copy number sequencing, supplemented by single cell analysis.